Pharma giant Pfizer got bigger on Monday, purchasing Wyeth Pharamceuticals for $65 billion in one of the few big business moves to get funding lately. This comes after several years of aggressive cost-cutting and huge layoffs at Pfizer, and was announced as the company released an annual report revealing a $2.3 billion settlement for offl-label marketing.
At least one Pfizer employee feels that Wyeth employees should be warned.
I feel sorry for the good people of Wyeth. You didn’t ask to be gobbled up by this monster. As for myself, I was just to lazy/stupid/complacent to leave. I got caught up remembering all the good times, and I forgot that they pretty much ended 10 years ago.
I imagine that many will have trouble summoning sympathy. Nevertheless, the change in culture at drug companies over the last 20 years or so, both in sales and research, makes an interesting study — a move, as more than one person in the business has said
, from a focus on finding and disseminating novel solutions to problems to rebranding and aggressively marketing not-so-novel solutions.
Hat tip: Peter Rost, who’s running for FDA commissioner.